Invention Grant
- Patent Title: Chromosome 3p21.3 genes are tumor suppressors
- Patent Title (中): 染色体3p21.3基因是肿瘤抑制因子
-
Application No.: US10445718Application Date: 2003-05-27
-
Publication No.: US07902441B2Publication Date: 2011-03-08
- Inventor: Lin Ji , John Dorrance Minna , Jack Roth , Michael Lerman
- Applicant: Lin Ji , John Dorrance Minna , Jack Roth , Michael Lerman
- Applicant Address: US TX Austin US DC Washington
- Assignee: Board of Regents, The University of Texas,The United States of America as represented by the Department of Health and Human Services
- Current Assignee: Board of Regents, The University of Texas,The United States of America as represented by the Department of Health and Human Services
- Current Assignee Address: US TX Austin US DC Washington
- Agency: Fulbright & Jaworski L.L.P.
- Main IPC: A61K48/00
- IPC: A61K48/00

Abstract:
Tumor suppressor genes play a major role in the pathogenesis of human lung cancer and other cancers. Cytogenetic and allelotyping studies of fresh tumor and tumor-derived cell lines showed that cytogenetic changes and allele loss on the short arm of chromosome 3 (3p) are most frequently involved in about 90% of small cell lung cancers and greater than 50% of non-small cell lung cancers. A group of recessive oncogenes, Fus1, 101F6, Gene 21 (NPRL2), Gene 26 (CACNA2D2), Luca 1 (HYAL1), Luca 2 (HYAL2), PL6, 123F2 (RaSSFI), SEM A3 and Beta* (BLU), as defined by homozygous deletions in lung cancers, have been located and isolated at 3p21.3.
Public/Granted literature
- US20040016006A1 Chromosome 3p21.3 genes are tumor suppressors Public/Granted day:2004-01-22
Information query